362 related articles for article (PubMed ID: 10774817)
41. Identification of a sensitive period for developmental programming that increases risk for uterine leiomyoma in Eker rats.
Cook JD; Davis BJ; Goewey JA; Berry TD; Walker CL
Reprod Sci; 2007 Feb; 14(2):121-36. PubMed ID: 17636224
[TBL] [Abstract][Full Text] [Related]
42. Transcriptional analysis of steroid hormone receptors in smooth muscle uterine leiomyoma tumors of postmenopausal patients.
Strissel PL; Swiatek J; Oppelt P; Renner SP; Beckmann MW; Strick R
J Steroid Biochem Mol Biol; 2007 Oct; 107(1-2):42-7. PubMed ID: 17646097
[TBL] [Abstract][Full Text] [Related]
43. Effect of Decapeptyl, an agonistic analog of gonadotropin-releasing hormone on estrogens, estrogen sulfates, and progesterone receptors in leiomyoma and myometrium.
Pasqualini JR; Cornier E; Grenier J; Vella C; Schatz B; Netter A
Fertil Steril; 1990 Jun; 53(6):1012-7. PubMed ID: 2140991
[TBL] [Abstract][Full Text] [Related]
44. Immunoreactive and estrogen-binding estrogen receptors, and progestin receptor levels in uterine leiomyomata and their parental myometrium.
Chrapusta S; Konopka B; Paszko Z; Sieinski W; Szamborski J
Eur J Gynaecol Oncol; 1990; 11(4):275-81. PubMed ID: 2245811
[TBL] [Abstract][Full Text] [Related]
45. Uterine leiomyomas express myometrial contractile-associated proteins involved in pregnancy-related hormone signaling.
Cesen-Cummings K; Houston KD; Copland JA; Moorman VJ; Walker CL; Davis BJ
J Soc Gynecol Investig; 2003 Jan; 10(1):11-20. PubMed ID: 12517588
[TBL] [Abstract][Full Text] [Related]
46. Regression of uterine leiomyomata in response to the antiprogesterone RU 486.
Murphy AA; Kettel LM; Morales AJ; Roberts VJ; Yen SS
J Clin Endocrinol Metab; 1993 Feb; 76(2):513-7. PubMed ID: 8432797
[TBL] [Abstract][Full Text] [Related]
47. [Effects of metformin on the expression of estrogen synthetase and ER mRNA in uterine leiomyoma tissues].
Wang SY; Xue Q; Zhou YF; Yin L
Zhonghua Fu Chan Ke Za Zhi; 2019 Apr; 54(4):249-254. PubMed ID: 31006191
[No Abstract] [Full Text] [Related]
48. Tranilast, an orally active antiallergic compound, inhibits extracellular matrix production in human uterine leiomyoma and myometrial cells.
Islam MS; Protic O; Ciavattini A; Giannubilo SR; Tranquilli AL; Catherino WH; Castellucci M; Ciarmela P
Fertil Steril; 2014 Aug; 102(2):597-606. PubMed ID: 24934492
[TBL] [Abstract][Full Text] [Related]
49. Molecular bases for the actions of ovarian sex steroids in the regulation of proliferation and apoptosis of human uterine leiomyoma.
Matsuo H; Kurachi O; Shimomura Y; Samoto T; Maruo T
Oncology; 1999 Oct; 57 Suppl 2():49-58. PubMed ID: 10545803
[TBL] [Abstract][Full Text] [Related]
50. Interleukin 8 production and interleukin 8 receptor expression in human myometrium and leiomyoma.
Senturk LM; Sozen I; Gutierrez L; Arici A
Am J Obstet Gynecol; 2001 Mar; 184(4):559-66. PubMed ID: 11262453
[TBL] [Abstract][Full Text] [Related]
51. A novel selective progesterone receptor modulator asoprisnil (J867) inhibits proliferation and induces apoptosis in cultured human uterine leiomyoma cells in the absence of comparable effects on myometrial cells.
Chen W; Ohara N; Wang J; Xu Q; Liu J; Morikawa A; Sasaki H; Yoshida S; Demanno DA; Chwalisz K; Maruo T
J Clin Endocrinol Metab; 2006 Apr; 91(4):1296-304. PubMed ID: 16464945
[TBL] [Abstract][Full Text] [Related]
52. G protein-coupled estrogen receptor 1 expression in normal myometrium, leiomyoma, and adenomyosis tissues of premenopausal women.
Kim M; Kim YS; Choi JI; Kim JM; Lee HH; Kim TH
Gynecol Endocrinol; 2020 Jul; 36(7):599-604. PubMed ID: 32321334
[TBL] [Abstract][Full Text] [Related]
53. Novel estrogenic action of the pesticide residue beta-hexachlorocyclohexane in human breast cancer cells.
Steinmetz R; Young PC; Caperell-Grant A; Gize EA; Madhukar BV; Ben-Jonathan N; Bigsby RM
Cancer Res; 1996 Dec; 56(23):5403-9. PubMed ID: 8968093
[TBL] [Abstract][Full Text] [Related]
54. Differential expression of microRNAs in myometrium and leiomyomas and regulation by ovarian steroids.
Pan Q; Luo X; Chegini N
J Cell Mol Med; 2008; 12(1):227-40. PubMed ID: 18182067
[TBL] [Abstract][Full Text] [Related]
55. Pirfenidone: a novel pharmacological agent that inhibits leiomyoma cell proliferation and collagen production.
Lee BS; Margolin SB; Nowak RA
J Clin Endocrinol Metab; 1998 Jan; 83(1):219-23. PubMed ID: 9435445
[TBL] [Abstract][Full Text] [Related]
56. Progesterone receptor messenger ribonucleic acid and protein are overexpressed in human uterine leiomyomas.
Brandon DD; Bethea CL; Strawn EY; Novy MJ; Burry KA; Harrington MS; Erickson TE; Warner C; Keenan EJ; Clinton GM
Am J Obstet Gynecol; 1993 Jul; 169(1):78-85. PubMed ID: 8333481
[TBL] [Abstract][Full Text] [Related]
57. Primary Human Uterine Leiomyoma Cell Culture Quality Control: Some Properties of Myometrial Cells Cultured under Serum Deprivation Conditions in the Presence of Ovarian Steroids.
Bonazza C; Andrade SS; Sumikawa JT; Batista FP; Paredes-Gamero EJ; Girão MJ; Oliva ML; Castro RA
PLoS One; 2016; 11(7):e0158578. PubMed ID: 27391384
[TBL] [Abstract][Full Text] [Related]
58. Uterine Leiomyoma Stem Cells: Linking Progesterone to Growth.
Bulun SE; Moravek MB; Yin P; Ono M; Coon JS; Dyson MT; Navarro A; Marsh EE; Zhao H; Maruyama T; Chakravarti D; Kim JJ; Wei JJ
Semin Reprod Med; 2015 Sep; 33(5):357-65. PubMed ID: 26251118
[TBL] [Abstract][Full Text] [Related]
59. Expression of exon 5 deleted estrogen receptor variant messenger RNA in human uterine myometrium and leiomyoma.
Mito K; Tamura T; Hosokawa K; Kondo T; Yamamoto T; Honjo H
J Steroid Biochem Mol Biol; 1998 Oct; 67(1):9-16. PubMed ID: 9780024
[TBL] [Abstract][Full Text] [Related]
60. Adenovirus-mediated delivery of a dominant-negative estrogen receptor gene in uterine leiomyoma cells abrogates estrogen- and progesterone-regulated gene expression.
Hassan MH; Salama SA; Arafa HM; Hamada FM; Al-Hendy A
J Clin Endocrinol Metab; 2007 Oct; 92(10):3949-57. PubMed ID: 17635941
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
